Jose Trevejo
2022
In 2022, Jose Trevejo earned a total compensation of $3M as Chief Medical Officer at Tarsus Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $176,000 |
| Option Awards | $1,642,347 |
| Salary | $403,333 |
| Stock Awards | $606,054 |
| Other | $40,057 |
| Total | $3,017,791 |
Trevejo received $1.6M in option awards, accounting for 54% of the total pay in 2022.
Trevejo also received $150K in bonus, $176K in non-equity incentive plan, $403.3K in salary, $606.1K in stock awards and $40.1K in other compensation.
Rankings
In 2022, Jose Trevejo's compensation ranked 1,210th out of 5,760 executives tracked by ExecPay. In other words, Trevejo earned more than 79.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,210 out of 5,760 | 79th |
Division Manufacturing | 584 out of 3,136 | 81st |
Major group Chemicals And Allied Products | 213 out of 1,422 | 85th |
Industry group Drugs | 192 out of 1,323 | 86th |
Industry Biological Products, Except Diagnostic Substances | 42 out of 291 | 86th |
Source: SEC filing on April 26, 2023.
Trevejo's colleagues
We found two more compensation records of executives who worked with Jose Trevejo at Tarsus Pharmaceuticals in 2022.